Gadolinium-based magnetic resonance imaging contrast agents in interventional radiology

Israel Medical Association Journal

Volumn 6, Issue 7, 2004, Pages 412-414

  Atar, Eli ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Contrast agent; Digital subtraction angiography; Gadolinium; Interventional radiology; Magnetic resonance angiography

Indexed keywords

ACETYLCYSTEINE; DOPAMINE 3 RECEPTOR STIMULATING AGENT; FENOLDOPAM; GADOLINIUM; IODINATED CONTRAST MEDIUM; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

ANAPHYLAXIS; CARDIOVASCULAR SYSTEM; CATHETERIZATION; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; HEADACHE; HEPATOBILIARY SYSTEM; HUMAN; INJECTION PAIN; INTERVENTIONAL RADIOLOGY; KIDNEY DYSFUNCTION; MAGNETIC RESONANCE ANGIOGRAPHY; NAUSEA AND VOMITING; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; URINARY TRACT;

CONTRAST MEDIA; GADOLINIUM; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; RADIOGRAPHY, INTERVENTIONAL; RADIOPHARMACEUTICALS;

EID: 3242884975     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Barret BJ. Contrast nephrotoxicity. J Am Soc Nephrol 1994;5:125-37.
2. Porter GA. Contrast associated nephropathy. Am J Cardiol 1989;64:22-6.
3. Westbrook C, Kaut C. MRI in practice. In: Vascular and Cardiac Imaging. 2nd edn. Portland, Oregon: Blackwell Science, 2000:187-200.
4. Stein B, Leary C, Ohki S. Magnetic resonance angiography: the nuts and bolts. Techniques Vasc Intervent Radiol 2001;4:27-44.
5. Hunter DW, Chamsuddin A, Bjarnason H, Kowalik K. Preventing contrast induced nephropathy with Fenoldopam. Techniques Vasc Intervent Radiol 2001;4:53-6.
6. Tepel M, van der Giet M, Schwarzfeld C. Prevention of radiographic contrast-agent-incluced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-4.
7. Atar E, Neuman-Levine M. Carbon dioxide angiography. Harefuah 1998;135(9):392-3 (Hebrew).
8. Rung BM. Safety of approved MRI contrast media for intravenous injection. Magn Reson Imaging 1992;12:205-13.
9. Shellock FG, Kanal E. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 1999;10:477-84.
10. Russo V, Minutolo R, Cianciaruso B. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 1995;6:1451-8.
11. Joffe P, Thomsen HS, Meusel M. Pharmacokinetics of gadolinium-based contrast agents as an alternative at vena cavography in patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis Acad Radiol 1998;5:491-502.
12. Spinosa DJ, Angle JF, Hartwell GD, Hagspiel KD, Leung DA, Matsumoto AH. Gadolinium-based contrast agents in angiography and interventional radiology. Radiol Clin North Am 2002;40:693-710.
13. Arat A, Cekirage HS, Saatci I. Gadodiamide as an alternative contrast medium in cerebral angiography in a patient with sensitivity to iodinated contrast medium. Neuroradiology 2000;42(1):34-7.
14. Spinosa DJ, Angle JF, Hagspiel KD. Feasibility of gadodiamide compared with iodinated contrast material for imaging of the abdominal aorta and renal arteries. J Vasc Interv Radiol 2000;11:733-7.
15. Spinosa DJ, Angle JF, Hapspiel KD, Jenkins AD, Matsumoto AH. Interventional procedures performed using gadodiamide as an alternative to iodinated contrast material. Cardiovasc Intervent Radiol 2000;23(1):72-4.